Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Stage Parkinson's Disease”

52 trials

Showing 20 of 52 results

Testing effectiveness (Phase 2)Ended earlyNCT00607451
What this trial is testing

Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia

Who this might be right for
Levodopa-induced Dyskinesia
Neurim Pharmaceuticals Ltd. 8
Large-scale testing (Phase 3)Study completedNCT01631825
What this trial is testing

A Long-Term Extension Trial From of SPM 962 in Advanced Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
Otsuka Pharmaceutical Co., Ltd. 321
Large-scale testing (Phase 3)Study completedNCT00522379
What this trial is testing

Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal Patch

Who this might be right for
Parkinson's Disease
UCB Pharma 514
Large-scale testing (Phase 3)UnknownNCT02605434
What this trial is testing

Assess the Safety and Efficacy of the of the Gastric-retentive AP-CD/LD in Advanced Parkinson's Patients

Who this might be right for
Parkinson's Disease
Intec Pharma Ltd. 420
Large-scale testing (Phase 3)Study completedNCT00200512
What this trial is testing

Continued Efficacy of Apomorphine After Previous Exposure of at Least Three Months

Who this might be right for
Parkinson Disease
Mylan Bertek Pharmaceuticals 16
Early research (Phase 1)Study completedNCT03665454
What this trial is testing

PF 06412562 in Subjects With Advanced Stage Parkinson's Disease

Who this might be right for
Parkinson Disease
Milton S. Hershey Medical Center 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT06722729
What this trial is testing

A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's Disease

Who this might be right for
Parkinson Disease
Kissei Pharmaceutical Co., Ltd. 150
Large-scale testing (Phase 3)Study completedNCT00134251
What this trial is testing

Ascending Dose Tolerability/Safety of SLV308 for the Treatment of Parkinson's Disease

Who this might be right for
Parkinson's Disease
Solvay Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT00501969
What this trial is testing

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advanced-Stage Parkinson's Disease

Who this might be right for
Advanced Stage Parkinson's Disease
UCB Pharma 395
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07028632
What this trial is testing

The Safety, Feasibility and Efficacy of NouvNeu001 for Parkinson's Disease

Who this might be right for
Parkinson Disease (PD)
iRegene Therapeutics Co., Ltd. 30
Testing effectiveness (Phase 2)Looking for participantsNCT07102342
What this trial is testing

This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease.

Who this might be right for
Parkinson Disease
iRegene Therapeutics Co., Ltd. 5
Large-scale testing (Phase 3)Study completedNCT00408915
What this trial is testing

Continuous Application of Lisuride in Parkinson's Disease by Subcutaneous Infusion

Who this might be right for
Parkinson's Disease
Axxonis Pharma AG 60
Large-scale testing (Phase 3)Study completedNCT02006121
What this trial is testing

Clinical Trial of Apomorphine Subcutaneous Infusion in Patients With Advanced Parkinson's Disease

Who this might be right for
Parkinson's Disease
Britannia Pharmaceuticals Ltd. 107
Early research (Phase 1)Study completedNCT03562494
What this trial is testing

VY-AADC02 for Parkinson's Disease With Motor Fluctuations (RESTORE-1)

Who this might be right for
Parkinson's Disease
Neurocrine Biosciences 14
Early research (Phase 1)Not Yet RecruitingNCT07550374
What this trial is testing

Phase I Clinical Study of NouvNeu001 Injection for the Treatment of Moderate-to-Advanced Parkinson's Disease in Patients Who Have Previously Undergone Deep Brain Stimulation or Deep Brain Nucleus Lesioning Surgery

Who this might be right for
Parkinson's Disease (PD)
iRegene Therapeutics Co., Ltd. 10
Not applicableStudy completedNCT02333175
What this trial is testing

Care for Late Stage Parkinsonism

Who this might be right for
Parkinson's DiseaseLate Stage Parkinson's Disease
University College, London 184
Testing effectiveness (Phase 2)Study completedNCT00438607
What this trial is testing

Dose-Finding Safety Study of BIIB014 in Combination With Levodopa in Moderate to Late Stage Parkinson's Disease

Who this might be right for
Parkinson's Disease
Biogen 83
Large-scale testing (Phase 3)Study completedNCT00145171
What this trial is testing

A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients.

Who this might be right for
Parkinson Disease
Mylan Bertek Pharmaceuticals 56
Testing effectiveness (Phase 2)Study completedNCT01631812
What this trial is testing

A Long-Term Extension Trial From Late Phase II of SPM 962 in Advanced Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
Otsuka Pharmaceutical Co., Ltd. 130
Not applicableLooking for participantsNCT06916507
What this trial is testing

Study to Assess Real Life Effectiveness of Foslevodopa/Foscarbidopa in Adult German Participants at Initial Stages of Advanced Parkinson's Disease (EARLY-FOS)

Who this might be right for
Parkinson's Disease
AbbVie 125
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation